Ivermectin 1% (CD5024) for the treatment of rosacea

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2018-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14656566.2018.1447562PMID 29544355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee

  2018influential reference
• Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.

  2017cited by this paper
• Pityriasis Folliculorum: Response to Topical Ivermectin

  2017cited by this paper
• Dual anti‐inflammatory and anti‐parasitic action of topical ivermectin 1% in papulopustular rosacea

  2017cited by this paper
• Demodex and rosacea revisited.

  2017cited by this paper
• Rosacea patients seeking advice: Qualitative analysis of patients’ posts on a rosacea support forum

  2016cited by this paper
• Rosacea Management

  2016cited by this paper
• Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36‐week extension of the ATTRACT randomized study

  2016cited by this paper
• Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States

  2016cited by this paper
• Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study

  2016cited by this paper
• The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis

  2016cited by this paper
• Topical and oral therapeutic approach to rosacea.

  2016cited by this paper
• Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea.

  2015cited by this paper
• Update on the management of rosacea

  2015cited by this paper
• Rosacea Patient Perspectives on Homeopathic and Over-the-counter Therapies.

  2015cited by this paper
• Rosacea: part II. Topical and systemic therapies in the treatment of rosacea.

  2015cited by this paper
• Interventions for Rosacea.

  2015cited by this paper
• Update on the Management of Rosacea.

  2015cited by this paper
• The treatment of rosacea with topical ivermectin.

  2015cited by this paper
• Ivermectin: A Review in Rosacea

  2015influential reference
• Management of cutaneous rosacea: emphasis on new medical therapies

  2014cited by this paper
• Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

  2014influential reference
• Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

  2014influential reference
• The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review

  2008cited by this paper
• The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review

  2008influential reference
• Clinical, Cosmetic and Investigational Dermatology Dovepress New Developments in the Treatment of Rosacea – Role of Once-daily Ivermectin Cream

  year unknowncited by this paper

• Comparison of the Effectiveness of Ivermectin 1% Cream and Ketoconazole 2% Cream in Treating Facial Seborrheic Dermatitis: A Double‐Blind, Randomized, Controlled Clinical Trial

  2026cites this paper
• Significance of Demodex folliculorum and Demodex brevis in Pathogenesis of Dermatological Diseases—Current State of Knowledge

  2025cites this paper
• Rosacea: Practical Guidance and Challenges for Clinical Management

  2024cites this paper
• Scalp Rosacea Treated with Topical Ivermectin

  2024cites this paper
• Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy

  2024cites this paper
• Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems

  2023cites this paper
• Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study

  2023cites this paper
• Ivermectin: A critical review on characteristics, properties and analytical Methods.

  2023cites this paper
• Greater rosacea severity correlates with greater adherence and improvement in a clinical study.

  2022cites this paper
• Multi-Transcriptomic Analysis and Experimental Validation Implicate a Central Role of STAT3 in Skin Barrier Dysfunction Induced Aggravation of Rosacea

  2022cites this paper
• Treatment strategies, including antibiotics, to target the immune component of rosacea

  2022cites this paper
• Advances in pharmacotherapy for rosacea: what is the current state of the art?

  2022cites this paper
• Crystal Structures of New Ivermectin Pseudopolymorphs

  2021cites this paper
• CCID_A_266879 751..758

  2020cites this paper
• Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

  2020cites this paper
• A Split-Face Study Assessing the Clinical Benefit, Tolerability and Subject Satisfaction of a Dermocosmetic in Subjects with Rosacea Associated with Erythema and Sensitive Skin

  2020cites this paper
• Real‐life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites

  2019cites this paper
• Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study

  2019cites this paper
• Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta‐analysis

  2019cites this paper
• Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

  2019cites this paper
• L’infestation palpébrale et faciale au Demodex folliculorum

  2019cites this paper
• Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis.

  2019cites this paper
• Treatment of Meibomian Gland Disease

  year unknowncites this paper